Thomas P. Haverty
No más puestos en curso
Perfil
Thomas P.
Haverty held several positions in the pharmaceutical industry, including Senior Director & Head-Therapeutic Area at Johnson & Johnson, Vice President-BioVentures Division at Merck & Co., Inc., Vice President-Global Clinical Research at Schering-Plough Research Institute, and Chief Medical Officer & Senior VP-Development at ImmusanT, Inc. He also worked as an Assistant Professor of Medicine at the University of Pennsylvania and The University of Alabama.
Haverty received his undergraduate degree from Stanford University and his doctorate from the University of California San Diego.
Antiguos cargos conocidos de Thomas P. Haverty.
| Empresas | Cargo | Fin |
|---|---|---|
| University of Pennsylvania | Corporate Officer/Principal | - |
| ELOXX PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | - |
| The University of Alabama | Corporate Officer/Principal | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Formación de Thomas P. Haverty.
| Stanford University | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas P. Haverty